Alex Viall3 min read
GRIP2 min read
Julie DiMauro14 min listen
DOJ said two companies tried to drive certain beneficiaries away because their disabilities could make coverage costly.
Julie DiMauro3 min read
At the annual pharmaceutical compliance event, speakers discussed the Gilead False Claims Case and Trump administration initiatives.
Julie DiMauro5 min read
At the annual pharmaceutical compliance event, panelists said the time for an empowered compliance department engaged in mindful monitoring is now.
Julie DiMauro5 min read
We discussed improper marketing strategies, upcoding and billing issues, defense strategies for fraud cases with Tama Kudman and Barry Posner.
Alexander Barzacanos7 min read
Two cases involving pharmaceutical companies highlight importance of adequate disclosure over payments to healthcare groups.
Julie DiMauro3 min read
Pilot program at DOJ will give immunity to executives providing information about corporate misconduct in which they were involved.
Julie DiMauro2 min read
Millions of dollars in bribes were paid to Ecuadorian government officials.
Julie DiMauro3 min read